GENETICS OF PREMENSTRUAL DYSPHORIC DISORDER
Maged Mahmoud Ali Ahmed Elshourbagy;
Abstract
Introduction
remenstrual syndrome (PMS) is characterized by
recurrent psychologic, somatic and/or behavioral
symptoms that occur specifically during the luteal phase of
the menstrual cycle, and resolve by menstruation. The
symptoms are severe enough to affect the quality of life. At
the end of the PMS spectrum comes the Premenstrual
dysphoric disorder (PMDD) with predominant psychologic
symptoms. PMDD is estimated to occur in 3% to 8% of
women with PMS.1 Although the exact cause of PMDD is
unknown, however, there is evidence implicate an underlying
dysregulation of serotonergic pathway.
Evidence from epidemiologic studies suggests
genetic factor contribution to PMDD.9-Most investigations
have focused on the serotonin transporter gene (SLC6A4),
which encodes a membrane-bound serotonin transporter
responsible for active reuptake of serotonin from the
synaptic cleft. It is also the site of action of selective
serotonin reuptake inhibitors (SSRIs) which proved to be
effective in the treatment of up to 70% of women suffering
from PM DD.
P
Summary and Conclusion
137
The most frequently studied polymorphism of
SLC6A4 is the serotonin transporter long promoter region
which comprises a complex of 20 to 23 base-pair (bp) repeat
elements. A 43 bp insertion/deletion that produces a long (L)
or a short (S) allele. The S variant has been associated with
lower transcriptional activity of SLC6A4 and has a been
linked to major depressive disorders and SSRI response in
Caucasian subjects.
A functional A/G single nucleotide polymorphism
(SNP rs25531) that is located immediately upstream of the
43 bp insertion/deletion site further classify the L allele to La
and Lg .23-24 The later has been shown to lower 5-HTT
expression in vitro. Because the SNP is very rare to be found
in the S alleles. Many studies currently consider 5-HTTLPR
as a triallelic marker: LA, LG and S(A or G). Functionally, both
alleles LG and S(A or G) are associated with low expression of
the transporter protein.
Objective:
To investigate whether the function serotonin
transporter long promoter region (5-HTTLPR) / rs25531
promoter polymorphism in the serotonin transporter gene is
associated with premenstrual dysphoric disorder.
remenstrual syndrome (PMS) is characterized by
recurrent psychologic, somatic and/or behavioral
symptoms that occur specifically during the luteal phase of
the menstrual cycle, and resolve by menstruation. The
symptoms are severe enough to affect the quality of life. At
the end of the PMS spectrum comes the Premenstrual
dysphoric disorder (PMDD) with predominant psychologic
symptoms. PMDD is estimated to occur in 3% to 8% of
women with PMS.1 Although the exact cause of PMDD is
unknown, however, there is evidence implicate an underlying
dysregulation of serotonergic pathway.
Evidence from epidemiologic studies suggests
genetic factor contribution to PMDD.9-Most investigations
have focused on the serotonin transporter gene (SLC6A4),
which encodes a membrane-bound serotonin transporter
responsible for active reuptake of serotonin from the
synaptic cleft. It is also the site of action of selective
serotonin reuptake inhibitors (SSRIs) which proved to be
effective in the treatment of up to 70% of women suffering
from PM DD.
P
Summary and Conclusion
137
The most frequently studied polymorphism of
SLC6A4 is the serotonin transporter long promoter region
which comprises a complex of 20 to 23 base-pair (bp) repeat
elements. A 43 bp insertion/deletion that produces a long (L)
or a short (S) allele. The S variant has been associated with
lower transcriptional activity of SLC6A4 and has a been
linked to major depressive disorders and SSRI response in
Caucasian subjects.
A functional A/G single nucleotide polymorphism
(SNP rs25531) that is located immediately upstream of the
43 bp insertion/deletion site further classify the L allele to La
and Lg .23-24 The later has been shown to lower 5-HTT
expression in vitro. Because the SNP is very rare to be found
in the S alleles. Many studies currently consider 5-HTTLPR
as a triallelic marker: LA, LG and S(A or G). Functionally, both
alleles LG and S(A or G) are associated with low expression of
the transporter protein.
Objective:
To investigate whether the function serotonin
transporter long promoter region (5-HTTLPR) / rs25531
promoter polymorphism in the serotonin transporter gene is
associated with premenstrual dysphoric disorder.
Other data
| Title | GENETICS OF PREMENSTRUAL DYSPHORIC DISORDER | Other Titles | تأثير الجينات الوراثية فى الاضطراب المزاجى ماقبل الطمث | Authors | Maged Mahmoud Ali Ahmed Elshourbagy | Issue Date | 2014 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.